Latest articles in Health
Researchers have developed a new mRNA cancer vaccine that could help fight multiple types of cancer. In mouse models of melanoma, the vaccine combined with a PD-1 inhibitor made even drug-resistant tumors more sensitive to treatment. Separately, a new Alzheimer's treatment called NeuroEPO from Cuba showed promising results in trials, with high-dose groups showing improvement while placebo groups declined.
Scientists at the University of Bristol have discovered a new blood test that detects damage to microscopic blood vessels years before heart or kidney disease symptoms appear. Published in Nature Communications, the test identifies biomarkers of endothelial damage that current tests miss. The breakthrough could enable preventative treatment for millions at risk.
A banned hallucinogenic drug called ibogaine is raising hopes for treating PTSD in military veterans. Clinical trials involving former service members suggest the potent compound derived from the African iboga plant could provide lasting relief from trauma symptoms. However, ibogaine is classified as a controlled substance in the US and banned in many countries due to safety concerns including heart risks.
An experimental hepatitis B drug may offer a 'functional cure' for some patients, according to early clinical trial data. The news comes as data shows about 8% of Americans lacked health insurance in 2025, a number that could rise. Researchers also found that being a night owl may affect heart health, but lifestyle changes can help.
The FDA approved neffy, the first epinephrine nasal spray for severe allergic reactions including anaphylaxis, on Wednesday. Developed by ARS Pharmaceuticals, the needle-free treatment delivers a single 2mg dose of epinephrine via nasal mist and is expected to improve access for patients afraid of injections.
A comprehensive research study confirms the extensive health benefits of regular physical activity. The study followed participants over several years, tracking various health metrics. Findings show reduced risk of chronic diseases and improved mental health among active individuals.
Clinical researchers reported positive results from a mid-stage trial of an experimental Alzheimer's therapy. The treatment targets protein accumulation in the brain using a novel mechanism different from existing approaches.
Medical research teams announced advancements in developing new treatment approaches. Clinical studies showed promising results in preliminary testing phases. Researchers plan expanded trials to further evaluate treatment effectiveness.
The United States has expanded its Ebola travel restrictions to include lawful permanent residents (green card holders), previously exempt from the 30-day ban. The Centers for Disease Control and Prevention says the extension is necessary to prevent the virus from entering the country as the outbreak in central Africa continues to spread.
Clinical trial results published in The Lancet reveal a novel vaccine provides protection against influenza, RSV, and common cold coronaviruses. The mRNA-based vaccine demonstrated 75 percent efficacy across virus types. Phase 3 trials expanding to include older adults and children.